Eradicating Helicobacter pylori infection can prevent gastric cancer

Analysis

People may accept the claim that H. pylori eradication prevents gastric cancer because the bacterium’s link to cancer is well established and the idea of a simple antibiotic cure is appealing. However, the relationship is nuanced: eradication markedly lowers risk but does not guarantee that cancer will not develop, especially if pre‑existing mucosal damage remains. Moreover, the success of prevention programmes hinges on accurate diagnosis, appropriate antibiotic choice based on resistance data, and confirmation of cure—steps that are often lacking in low‑resource settings. Understanding these nuances matters because policymakers may allocate resources to nationwide screening without addressing resistance surveillance or follow‑up testing, potentially leading to limited benefit and increased antibiotic pressure. Communicating that eradication is a powerful, but not absolute, preventive measure helps set realistic expectations and underscores the need for comprehensive strategies, including dietary modifications and monitoring of gastric precancerous lesions.